Company intelligence / Profile preview

Wilhelm Beier

Grünwald, Germany

Ownership: Private
Development stage: Other

Overview

Dermapharm is a market leader in Germany for prescription dermatologicals and vitamins, with over 1,300 marketing authorizations and more than 390 active pharmaceutical ingredients produced in-house

Therapeutic areas: ImmunologyDermatology
Modalities: Small molecule
Industry: Biotech

Partnerships

BioNTech (COVID-19 vaccine manufacturing partnership)Canopy Growth Corporation (prior to 2022 acquisition of C³ Group)

Beyond the preview

Go deeper on Wilhelm Beier.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Wilhelm Beier.

Explore the full profile